RecruitingNCT06801821

Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis


Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Enrollment

400 participants

Start Date

Feb 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Primary objective: The primary objective is to evaluate in the general population the difference between emotional reactions associated with facial involvement by four major dermatologic diseases: psoriasis, atopic dermatitis, vitiligo, and alopecia areata. * Compare the social distance and stereotyping by the general population toward individuals with facial involvement by: psoriasis, atopic dermatitis, vitiligo, and alopecia areata. * Evaluate demographic factors that describe a greater tendency toward stigmatization.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Patients aged\>18 years, both sexes;
  • Signature of written informed consent;

Exclusion Criteria3

  • Patients diagnosed with psoriasis, atopic dermatitis, vitiligo or alopecia areata.
  • Patients with first-degree relatives with psoriasis, atopic dermatitis, vitiligo or alopecia areata
  • Those who for professional or personal reasons have direct knowledge of the diseases in question.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Dermatologia

Roma, Italia, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06801821


Related Trials